Chronic hemodialysis patients. Chronic kidney disease (CKD)
Conditions
Interventions
Intervention 1: Intervention group: In this group, oral Pearl Vit D3-50000 unit per week (Dana Pharma CO., Iran) will be prescribed for 3 months. Intervention 2: Intervention group: In this group, Cal
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age more than 18 years Hemodialysis patients who have been on dialysis for at least three months Vitamin D level less than 30 ng/mL Consent to participate in the study
Exclusion criteria
Exclusion criteria: Any active or chronic infection Magnesium supplementation Chronic diarrhea Hyperparathyroidism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum magnesium level. Timepoint: Before and after treatment (three months later). Method of measurement: Based on laboratory results measured by magnesium kit (Pars Azmoon,Iran).;Serum vitD (25-OH-VitD) level. Timepoint: Before and after treatment (three months later). Method of measurement: Based on laboratory results measured by Vit D kit (Monobind,Iran). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEbrahim Hamreh
Ahvaz University of Medical Sciences
Outcome results
None listed